Thursday 29 March 2018

STAT/Casey Ross: How will Amazon revolutionize health care? Follow its footprints in Seattle

STAT
  
Business
How will Amazon revolutionize health care? Follow its footprints in Seattle   

By Casey Ross @caseymross

February 12, 2018   
Pedestrians walk past the Amazon headquarters in downtown Seattle.
Ted S. Warren/AP

    Twitter
    Facebook
    LinkedIn
    Email
    Doximity
    Republish
    Print

A

mazon’s effort to shake up health care is as tantalizing as it is opaque — a giant black box hanging over one-fifth of the American economy.

But several clues about its plans are plainly visible in its hometown of Seattle, where it has hired executives from health industry heavyweights and spurred adoption of technologies it may eventually use to upend drug distribution and other aspects of care.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

What is STAT Plus?

    Twitter
    Facebook
    LinkedIn
    Email
    Doximity
    Republish
    Print

Leave a Comment
Name
Email Address
Comment
Notify me of followup comments via e-mail

    Paul Akre
    February 13, 2018 at 10:28 am

    Good article
    Reply

Trending
Heroin and Fentanyl doses   
Why fentanyl is deadlier than heroin, in a single photo
Drug Take Back
Pharmalot
Recommended Stories
Lamar Alexander   
Politics
Why do we need drug rebates, anyway? A top lawmaker wants to know

By Ike Swetlitz
PUERTORICO-Hurricane recovery   
Pharma
FDA: Drug and device companies in Puerto Rico still operating far below capacity after storm

By Ike Swetlitz

Jerry Brown   
The Pharmalot View
California just passed a law to rein in drug prices. Here’s why it’s unlikely to make much difference

By Ed Silverman
Vitamin pills   
Business
The FTC takes the long view in effort to foster prescription drug competition

By Ike Swetlitz
Calculator   
Pharma
Trump wants to cut Big Pharma’s tax bill, but what are drug makers actually paying?

By Damian Garde

Reporting from the frontiers of health and medicine
STAT

    About Us
    Contact Us
    The STAT Team
    Awards for STAT
    Work at STAT
    Advertise

Back to Top

    Privacy
    Comment Policy
    Terms

© 2018 STAT

No comments: